Israel 150 Logo

Israeli companies listed on US stock exchanges

PolyPid Ltd. (PYPD)


Sector: Medical

Industry: Medical - Drugs

Exchange: Nasdaq

18 Hasivim Street, P.O Box 7126 Petach Tikva, Israel 4917002

IR Contact info

Name: Ori Warshavsky

Title: Chief Operating Officer - US Operations


Tel: +1.267.640.7592

PYPD on Major Financial Platforms:
  • Nasdaq

Polypid is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid's proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid's lead product candidate D-PLEX100 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma.

The Executives
Dikla Czaczkes Akselbrad,CEO
Dalit Hazan,EVP, R&D, Clinical and Regulatory Affairs
Ori Warshavsky ,COO
Jonny Missulawin,CFO
Jean-Marc Hagai,CCO
Video Presentations